Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Abstract

This paper introduces a framework with which to conceptualise the decision-making process in health technology assessment for new interventions with high budgetary impacts. In such circumstances, the use of a single threshold based on the marginal productivity of the health care system is inappropriate. The implications of this for potential partial implementation, horizontal equity and pharmaceutical pricing are illustrated using this framework.

Under the condition of perfect divisibility and given an objective of maximising health, a large budgetary impact of a new treatment may imply that optimal implementation is partial rather than full, even at a given incremental costeffectiveness ratio that would nevertheless mean the decision to accept the treatment in full would not lead to a net reduction in health. In a one-shot price-setting game, this seems to give rise to potential horizontal equity concerns. When the assumption of fixity of the ICER (arising from the assumed exogeneity of the manufacturer’s price) is relaxed, it can be shown that the threat of partial implementation may be sufficient to give rise to an ICER at which cost the entire potential population is treated, maximising health at an increased level, and with no contravention of the horizontal equity principle.

Biography

Dan is a Senior Research Fellow in the Academic Unit of Health Economics within the Leeds Institute of Health Sciences. He joined AUHE in May 2018 after two years as a Postdoc in Health Economics at the University of Groningen. Prior to this, he held various teaching and research fellow positions at University College London and the University of York. His research interests include the impact of early life circumstances on late life health outcomes and the distribution of healthcare expenditures late in life

Forthcoming events

NDPH Seminar - Changing the way medical research is funded: Some lessons from Australia

Thursday, 26 September 2019, 4pm to 5pm @ Seminar rooms, BDI, Old Road Campus, OX3 7LF

Ethox/WEH Seminar - Reclaiming a Sense of Common Humanity: A Confucian Ethical Vision

Wednesday, 02 October 2019, 11am to 12.30pm @ Level 1 Ax Meeting Room, BDI, Old Road Campus, OX3 7LF

UVBO Seminar - Can wearable sensors and machine learning enhance our understanding of lifestyle health behaviours?

Thursday, 17 October 2019, 1pm to 2pm @ L1 Meeting room, Richard Doll Building, Old Road Campus, OX3 7LF

UVBO Seminar - Nutrient timing and human health

Thursday, 24 October 2019, 1pm to 2pm @ School of Anthropology, 61 Banbury Road, OX2 6PE

Pharmaceutical policies in the long run: reflections on 60th anniversary of the Hinchliffe Report

Monday, 11 November 2019, 9.30am to 5pm @ Merton College, Merton Street Oxford, OX1 4JD

Designing and Running Streamlined Randomized Trials

Monday, 13 January 2020 to Tuesday, 14 January 2020, 9.30am - 5pm